Open Access

How could factor eleven (FXI) inhibitors help your patients? New frontiers in thrombosis prevention

Event: ESC Congress 2022
Topic: Atrial Fibrillation (AF)
Session type: Satellite Symposium
Sponsored by Bayer AG
Date: 29 August 2022
Time: 15:30 - 16:15

Congress Session

4 presentations in this session

Welcome and introduction.

Speaker: Doctor M. Patel (Durham, US)
Thumbnail

What makes FXI inhibition different from current approaches to thrombosis prevention?

Speaker: Professor V. Caso (Perugia, IT)
Thumbnail

Which patients will benefit most from FXI inhibition?

Speaker: Professor V. Kunadian (Newcastle-Upon-Tyne, GB)
Thumbnail

Live Q&A.

Thumbnail

3 speakers from this session

Doctor Manesh Patel

Duke University Medical Center, Durham (United States of America)
28 presentations
1 follower

Professor Valeria Caso

Hospital Santa Maria Della Misericordia, Perugia (Italy)
5 presentations
2 followers

Professor Vijay Kunadian

Newcastle University, Newcastle-Upon-Tyne (United Kingdom of Great Britain & Northern Ireland)
10 presentations
1 follower

This platform is supported by

logo Novo Nordisk